Thermo Fisher Scientific Inc (NYSE:TMO) Position Lowered by E&G Advisors LP

E&G Advisors LP reduced its holdings in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 25.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,745 shares of the medical research company’s stock after selling 600 shares during the period. E&G Advisors LP’s holdings in Thermo Fisher Scientific were worth $330,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in TMO. Proficio Capital Partners LLC increased its position in shares of Thermo Fisher Scientific by 71.5% in the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after purchasing an additional 253 shares during the last quarter. Chicago Partners Investment Group LLC purchased a new stake in shares of Thermo Fisher Scientific in the 2nd quarter valued at approximately $108,000. Cribstone Capital Management LLC increased its position in shares of Thermo Fisher Scientific by 8.7% in the 2nd quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 50 shares during the last quarter. Shine Investment Advisory Services Inc. purchased a new stake in shares of Thermo Fisher Scientific in the 2nd quarter valued at approximately $113,000. Finally, Ropes Wealth Advisors LLC increased its position in shares of Thermo Fisher Scientific by 15.8% in the 2nd quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after purchasing an additional 97 shares during the last quarter. 86.16% of the stock is currently owned by hedge funds and other institutional investors.

In other news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now owns 252,577 shares in the company, valued at approximately $47,582,981.03. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.49% of the stock is currently owned by company insiders.

A number of research analysts recently commented on the stock. Cowen reaffirmed an “outperform” rating and issued a $220.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Leerink Swann increased their target price on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the company an “outperform” rating in a research report on Monday, October 9th. Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday, October 26th. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, October 30th. Finally, Goldman Sachs Group assumed coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, September 26th. They issued a “buy” rating and a $225.00 target price on the stock. One analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus target price of $205.21.

Shares of Thermo Fisher Scientific Inc (TMO) traded up $1.42 during trading hours on Wednesday, reaching $183.87. 2,262,940 shares of the company were exchanged, compared to its average volume of 1,561,328. The firm has a market cap of $72,570.00, a PE ratio of 20.00, a P/E/G ratio of 1.67 and a beta of 1.06. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. Thermo Fisher Scientific Inc has a 12-month low of $139.88 and a 12-month high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.24 by $0.07. The firm had revenue of $5.12 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. Thermo Fisher Scientific’s quarterly revenue was up 13.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.03 EPS. analysts anticipate that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.33%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.19%.

ILLEGAL ACTIVITY WARNING: “Thermo Fisher Scientific Inc (NYSE:TMO) Position Lowered by E&G Advisors LP” was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://stocknewstimes.com/2017/12/06/eg-advisors-lp-decreases-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply